Glen Harbor Capital Management’s United Therapeutics UTHR Stock Holding History

Glen Harbor Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$610K	Sell	7,648 -5,920	-44%	-$477K	0.01%	635
2019 Q2	$1.06M	Sell	13,568 -6,720	-33%	-$628K	0.02%	463
2019 Q1	$2.38M	Sell	20,288 -13,200	-39%	-$1.54M	0.05%	291
2018 Q4	$3.65M	Buy	33,488 +2,352	+8%	+$273K	0.09%	223
2018 Q3	$3.98M	Buy	31,136 +8,160	+36%	+$1.01M	0.08%	240
2018 Q2	$2.6M	Buy	22,976 +4,736	+26%	+$521K	0.06%	289
2018 Q1	$2.05M	Buy	18,240 +13,472	+283%	+$1.71M	0.05%	287
2017 Q4	$705K	Buy	4,768 +1,840	+63%	+$234K	0.02%	538
2017 Q3	$343K	Sell	2,928 -9,360	-76%	-$1.2M	0.01%	720
2017 Q2	$1.59M	Sell	12,288 -4,496	-27%	-$561K	0.04%	329
2017 Q1	$2.27M	Sell	16,784 -7,168	-30%	-$1.09M	0.06%	277
2016 Q4	$3.44M	Buy	+23,952	New	+$3.06M	0.09%	180

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Glen Harbor Capital Management's UTHR Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its United Therapeutics (UTHR) stake by 44% in Q3 2019, selling an estimated $477K and leaving 7,648 shares worth $610K. The position accounts for 0.01% of the portfolio, ranked #635.

Glen Harbor Capital Management first reported a position in UTHR in Q4 2016 and has held it in 12 quarters since. The position peaked at $3.98M in Q3 2018. 302 funds tracked by Wall St. Rank hold UTHR as of Q3 2019.

Glen Harbor Capital Management held 7,648 shares of United Therapeutics worth $610K as of Q3 2019.
Glen Harbor Capital Management sold 5,920 United Therapeutics shares in Q3 2019, an estimated $477K.
United Therapeutics made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #635 holding.
Glen Harbor Capital Management first reported a position in United Therapeutics in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's United Therapeutics position peaked at $3.98M in Q3 2018.
302 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.